Skip to main content
. Author manuscript; available in PMC: 2012 Jul 10.
Published in final edited form as: Methods Mol Biol. 2009;539:175–190. doi: 10.1007/978-1-60327-003-8_10

Fig. 2.

Fig. 2

The cytotoxicity of PrAg-U2 to uPAR-expressing tumor cells is blocked by PAI-1. HeLa cells were cultured to 50% confluence, preincubated with serum-free DMEM containing 100 ng/ml of pro-uPA and 1 μg/ml of Glu-plasminogen with or without 2 μg/ml of PAI-1 for 30 min. Then PrAg and PrAg-U2 combined with FP59 (50 ng/ml) were added to the cells and incubated for 6 h. The toxins were removed and replaced with fresh serum-containing DMEM. MTT was added to determine cell viability at 48 h.

HHS Vulnerability Disclosure